Browse Category

Legal Updates News 16 January 2026 - 3 February 2026

Meta stock price slips after-hours as New Mexico child-safety trial starts and AI capex stays in focus

Meta stock price slips after-hours as New Mexico child-safety trial starts and AI capex stays in focus

Meta shares fell 1.4% to $706.41 in after-hours trading Monday after jury selection began in a New Mexico civil case alleging the company enabled child exploitation. The drop followed Meta’s warning of rising legal risks and projected 2026 expenses up to $169 billion. Broader markets rose, with the S&P 500 up 0.5%. Opening statements in the New Mexico trial are set for Feb. 9.
ANZ share price heads into Australia Day shutdown as CPI and NZ court case come into focus

ANZ share price heads into Australia Day shutdown as CPI and NZ court case come into focus

ANZ shares closed at A$36.21 Friday, down 0.5%, while the S&P/ASX 200 edged up 0.13%. The ASX will be shut Monday for Australia Day, leaving investors waiting for Wednesday’s inflation data and updates on a New Zealand class-action suit. ANZ continues to fight the claims, with hearings set for March. The Australian dollar traded near 68.47 U.S. cents.
Novo Nordisk Class B stock heads into Monday with Wegovy pill scripts and Victoza lawsuit in focus

Novo Nordisk Class B stock heads into Monday with Wegovy pill scripts and Victoza lawsuit in focus

Novo Nordisk Class B shares closed up 1.17% at 401.35 crowns in Copenhagen, lifted by strong early U.S. demand for its new Wegovy pill. The company faces a new U.S. lawsuit alleging a “pay-for-delay” scheme for Victoza. Over 18,000 Wegovy pill prescriptions were reported in the U.S. since its Jan. 5 launch. Indian regulators approved local firms to make generic semaglutide ahead of the 2026 patent expiry.
Virgin Media pension ruling fallout: UK FRC issues new actuary guidance as “section 37” fix nears

Virgin Media pension ruling fallout: UK FRC issues new actuary guidance as “section 37” fix nears

Britain’s Financial Reporting Council has issued new guidance for pension scheme actuaries after the Virgin Media case exposed risks from missing written actuarial sign-offs on historic rule changes. The government plans legislation to let schemes validate old amendments, but the FRC warns some schemes could face higher liabilities. The guidance may be updated as the Pensions Schemes Bill advances. Not all schemes or disputes will be covered by the proposed fix.
24 January 2026
StubHub stock: Friday lead-plaintiff deadline nears in IPO cash flow lawsuit

StubHub stock: Friday lead-plaintiff deadline nears in IPO cash flow lawsuit

StubHub shareholders have until Jan. 23 to seek lead-plaintiff status in a class action over its September IPO. The lawsuit alleges the company hid changes in vendor payment timing that cut free cash flow. STUB shares closed at $15.06 Thursday, down 36% from the $23.50 IPO price. The complaint names StubHub, top executives, and major underwriters.
BigBear.ai stock slips premarket as investors brace for Jan. 22 share vote and fresh law-firm probe

BigBear.ai stock slips premarket as investors brace for Jan. 22 share vote and fresh law-firm probe

BigBear.ai shares fell 3.1% to $5.94 in premarket trading Wednesday ahead of a key shareholder vote on authorizing more shares. Investors must vote by Jan. 21 for the Jan. 22 meeting, as a law firm investigates possible securities claims. The company recently converted $125 million in debt to equity. CEO Kevin McAleenan urged support for the proposal, citing low available shares.
CrowdStrike stock price today: CRWD steadies after China ban report and outage lawsuit dismissal

CrowdStrike stock price today: CRWD steadies after China ban report and outage lawsuit dismissal

CrowdStrike shares closed up 0.2% at $455.91 Friday after the company said it expects minimal impact from China’s push to replace foreign cybersecurity software. A U.S. judge dismissed a shareholder lawsuit over the 2024 outage, though Delta Air Lines’ suit continues. CEO George Kurtz’s trust filed to potentially sell $9.66 million in shares. Broader market activity remained cautious ahead of the long weekend.
Eli Lilly stock slides premarket after FDA sets April 10 target for weight-loss pill decision, GLP-1 lawsuit filed

Eli Lilly stock slides premarket after FDA sets April 10 target for weight-loss pill decision, GLP-1 lawsuit filed

Eli Lilly shares fell 3.8% premarket to $1,033 after FDA documents set an April 10 decision date for its weight-loss pill under a fast-track program. Strive Specialties sued Lilly and Novo Nordisk in Texas, alleging efforts to block cheaper compounded GLP-1 drugs. Novo Nordisk shares dropped 3%. Investors await further FDA guidance and Lilly’s Feb. 4 earnings call.
1 2 3 6

Stock Market Today

Ashtead share price in focus as buyback rolls on and NYSE switch clocks closer

Ashtead share price in focus as buyback rolls on and NYSE switch clocks closer

7 February 2026
Ashtead shares closed Friday at 4,936p, up 1.09%, after the company bought 88,872 shares under its repurchase program. The group is set to shift its primary listing to New York on March 2, pending court approval, and will be removed from the FTSE UK index the same day. Ashtead paid a half-year dividend of 37.5 U.S. cents per share on Friday.
Beazley share price: big funds reshuffle stakes as Zurich bid deadline nears

Beazley share price: big funds reshuffle stakes as Zurich bid deadline nears

7 February 2026
Beazley shares closed flat at 1,236 pence Friday as BlackRock disclosed a 6.55% stake and Vanguard reported 5.02%. Wellington Management cut its holding below 5%. The disclosures follow Zurich Insurance’s possible takeover offer of up to 1,335 pence per share, with a Feb. 16 deadline for a firm bid.
Go toTop